Skip to content

Effect on Cerebral Oxygenation by Sevoflurane or Propofol Using Near-infrared Spectroscopy in Carotid Endarterectomy

Comparison the Effect on Cerebral Oxygenation by Sevoflurane-remifentanil or Propofol-remifentanil Anesthesia Using Near-infrared Spectroscopy in Patients Undergoing Carotid Endarterectomy)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02609087
Enrollment
69
Registered
2015-11-20
Start date
2015-08-31
Completion date
2016-12-31
Last updated
2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Stenosis

Brief summary

The aim of this study is comparing the effect on cerebral oxygenation by sevoflurane-remifentanil or propofol-remifentanil anesthesia in patient undergoing carotid endarterectomy. Cerebral oxygenation is measured by near-infrared spectroscopy. Sevoflurane and propofol reduce the cerebral metabolic rate for oxygen in similar degree. Propofol decrease the cerebral blood flow by dose-dependent manner, however, sevoflurane increase the cerebral blood flow in the concentration of avobe 1 MAC. Both drugs are widely used in general anesthesia for neurosurgical procedure, and their effect on cerebral oxygenation are acceptable. There is little data about the effect of general anethetics on cerebral oxygenation in patients undergoing carotid endarterectomy, who have imparied cerebral circulation. Our hypothesis is sevoflurane will show better cerebral oxygenation than propofol in patient have impaired cerebral circulation.

Detailed description

This study is performed by monitoring the cerebral oxygenation using near-infrared spectroscopy from general anesthesia induction to 10 min after releasing the carotid artery clipping. Study group: Sevoflurane - remifentanil anesthesia group (S) Propofol - remifentanil anesthesia group (R) Monitoring: near-infrared spectroscopy (SOMA sensor) BIS, HR, arterial blood pressure, SpO2, body temperature Patient seletion * inclusion criteria * American Society of Anesthesiologist (ASA) physical status 1-3 * 18 \ 70 years * patient who agree with informed concent * exclusion criteria * ASA physical status \> 4 * preoperative SpO2 \< 97% * patient who has other neurologic disease not related to carotid endarterectomy

Interventions

DRUGSevoflurane
DRUGPropofol

Sponsors

Chonnam National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologist (ASA) physical status 1-3 * 18 \ 70 years * patient who agree with informed consent

Exclusion criteria

* ASA physical status \> 4 * preoperative SpO2 \< 97% * patient who has other neurologic disease not related to carotid endarterectomy

Design outcomes

Primary

MeasureTime frame
cerebral oxygenation measured by near-infrared spectroscopyone year

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026